Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-69
SponsorNorwegian Institute of Public Health

About this trial

1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress levels as compared to a control group. Second, whether these interventions can improve HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a control group.

Eligibility criteria

Qualifiers

first occurrence breast cancer diagnosed from Jan 1, 2020

non-metastatic cancer stage 0-III

HER2 positive (regardless of ER, PR) or

ER negative

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Stressproffen cognitive based stress management
  • Stressproffen mindfulness based intervention
  • Control

Treatment groups

390 Participants
are divided into 3 treatment groups